Cathy Pareto & Associates, Inc Abb Vie Inc. Transaction History
Cathy Pareto & Associates, Inc
- $113 Billion
- Q1 2025
A detailed history of Cathy Pareto & Associates, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Cathy Pareto & Associates, Inc holds 1,694 shares of ABBV stock, worth $293,045. This represents 0.31% of its overall portfolio holdings.
Number of Shares
1,694
Previous 1,799
5.84%
Holding current value
$293,045
Previous $320 Million
11.0%
% of portfolio
0.31%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,139Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$29.9 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$13.8 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$8.95 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$6.87 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $306B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...